Will pharmaceutical firms survive global giants’ onslaught?

Korean pharmaceutical companies are feeling pressure from all sides. Relying too much on selling cheap generic drugs instead of developing original drugs, they lack competitiveness to take on global players, according to analysts.

On its part, the government forced the languishing domestic drug makers to substantially cut prices last April, further chipping away at their bottom lines.

T...